the dose-response relationship of single doses of nebulized metaproterenol sulfate 5 % inhalant solution was evaluated by placebo-controlled , parallel-group study of 30 children , aged 3 to 6 years old , with stable asthma .
C0978480
metaproterenol
C0004096
asthma